The porous polyethylene/bioglass spherical orbital implant: A retrospective study of 170 cases

Ophthalmic Plastic and Reconstructive Surgery

Volumn 27, Issue 1, 2011, Pages 21-27

  Ma, Xiaoping ^a   Schou, Kevin R ^b   Maloney Schou, Maureen ^b   Harwin, Fredric M ^b   Ng, John D ^b  

^a FUDAN UNIVERSITY   (China)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; POLYETHYLENE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONJUNCTIVA; ECTROPION; ENUCLEATION; EYE SURGERY; FEMALE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; ORBIT IMPLANT; ORBIT RECONSTRUCTION; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RETROSPECTIVE STUDY; SCHOOL CHILD; SURGICAL INFECTION; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; CERAMICS; CHILD; CHILD, PRESCHOOL; EYE ENUCLEATION; EYE, ARTIFICIAL; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; ORBIT; ORBITAL IMPLANTS; POLYETHYLENE; POROSITY; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES;

EID: 78751646922     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e3181de01a7     Document Type: Article

References (31)

1. Karesh JW, Dresner SC. High-density porous polyethylene (Med-por) as a successful anophthalmic socket implant. Ophthalmology 1994;101:1688-95.
2. Jordan DR, Brownstein S, Dorey M, et al. Fibrovascularization of porous polyethylene (Medpor) orbital implant in a rabbit model. Ophthal Plast Reconstr Surg 2004;20:136-43.
3. Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthal Plast Reconstr Surg 2004;20:274-80.
4. Nunery WR, Cepela MA, Heinz GW, et al. Extrusion rate of silicone spherical anophthalmic socket implants. Ophthal Plast Reconstr Surg 1993;9:90-5.
5. Custer PL, Trinkaus KM. Porous implant exposure: incidence, management, and morbidity. Ophthal Plast Reconstr Surg 2007; 23:1-7.
6. Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants. Report of six cases. Ophthalmology 1992;99:831-6.
7. Jordan DR, Brownstein S, Jolly SS. Abscessed hydroxyapatite orbital implants. A report of two cases. Ophthalmology 1996;103: 1784-7.
8. Kim YD, Goldberg RA, Shorr N, et al. Management of expoed hydroxyapatite orbital implant. Ophthalmology 1994;101:1709-15.
9. Nunery WR, Heinz GW, Bonnin JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopatho-logic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993;9:96-104.
10. Oestreicher JH, Liu E, Berkowitz M. Complications of hydroxy-apatite orbital implants. A review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology 1997;104:324-9.
11. Shoamanesh A, Pang NK, Oestreicher JH. Complication of orbital implants:a review of 542 patients who have undergone orbital implantation and 275 subsequent PGE placements. Orbit 2007;26: 173-82.
12. Yoon JS, Lew H, Kim SJ, et al. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases. Ophthalmology 2008;115:566-72.
13. Rubin PA, Popham JK, Bilyk JR, et al. Comparison of fibrovas-cular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 1994;10:96-103.
14. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
15. Amato MM, Blaydon SM, Scribbick FW Jr, et al. Use of bioglass for orbital volume augmentation in enophthalmos: a rabbit model (Oryctolagus cuniculus). Ophthal Plast Reconstr Surg 2003;19: 455-65.
16. Inkster CF, Ng SG, Leatherbarrow B. Primary banked scleral patch graft in the prevention of exposure of hydroxyapatite orbital implants. Ophthalmology 2002;109:389-92.
17. Seiff SR, Chang JS Jr, Hurt MH, et al. Polymerase chain reaction identification of human immunodeficiency virus-1 in preserved human sclera. Am J Ophthalmol 1994;118:528-30.
18. Wang JK, Liao SL, Lai PC, et al. Prevention of exposure of porous orbital implants following enucleation. Am J Ophthalmol 2007; 143:61-7.
19. Badilla J, Dolman PJ. Methods of antibiotic instillation in porous orbital implants. Ophthal Plast Reconstr Surg 2008;24:287-9.
20. Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992; 113:669-13.
21. Blaydon AM, Shepler TR, Neuhaus RW, et al. The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases. Ophthal Plast Reconstr Surg 2003;19:364-71.
22. Alwitry A, West S, King J, et al. Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration. Ophthal Plast Reconstr Surg 2007;23:11-5.
23. Trichopoulos N, Augsburger JJ. Enucleation with unwrapped porous and nonporous orbital implant: a 15-year experience. Ophthal Plast Reconstr Surg 2005;21:331-6.
24. Wilson J, Clark AE, Hall M, et al. Tissue response to bioglass endosseous ridge maintenance implants. J Oral Implantol 1993; 19:295-302.
25. Price N, Bendall SP, Frondoza C, et al. Human osteoblast-like cells (MG63) proliferate on a bioactive glass surface. J Biomed Mater Res 1997;37:394-400.
26. Oonishi H, Kushitani S, Yasukawa E, et al. Particulate Bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthop Relat Res 1997;334:316-25.
27. Bosetti M, Zanardi L, Hench L, et al. Type I collagen production by osteoblast-like cells cultured in contact with different bioactive glasses. J Biomed Mater Res A 2003;64:189-95.
28. Keeting PE, Oursler MJ, Wiegand KE, et al. Zeolite A increases proliferation, differentiation, and transforming growth factor [beta] production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res 1992;7:1281-9.
29. Choi HY, Lee JE, Park HJ, et al. Effect of synthetic bone glass particulate on the fibrovascularization of porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 2006;22:121-5.
30. Naik MN, Murthy RK, Honavar SG. Comparison of vasculariza-tion of Medpor and Medpor-plus orbital implants: a prospective, randomized study. Ophthal Plast Reconstr Surg 2007;23:463-7.
31. Holck DEE, Ng JD, Dacey K, et al. Using synthetic bone glass particulate to increase the rate of fibrovascular ingrowth in porous polyethylene orbital implants. American Society of Ophthalmic Plastic and Reconstructive Surgery Fall Scientific Symposium. New Orleans 2001.